WALLBOX N V C/WTS 01/10/2026 (TO PUR COM)

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

WBXWF

WBX+

Wallbox (NYSE:WBX) is set to release its Q1 2026 earnings on May 6, with analysts predicting a loss of $1.81 per share and revenue of $40.64 million. In its last earnings report, Wallbox reported a loss of $0.16 per share, exceeding expectations. The stock is currently rated as 'Hold' by analysts, with a consensus target price of $5.00. UBS recently lowered its price target from $4.00 to $3.00. Wallbox specializes in electric vehicle charging solutions and has a global presence.

Market Beat

Wallbox NV

Generac

UBS Group AG

Wallbox (WBX) Projected to Post Quarterly Earnings on Wednesday

Wallbox Signs Comprehensive Restructuring Plan and Secures €11 Million in Interim Financing | WBX Stock News

StockTitan

Wallbox Signs Comprehensive Restructuring Plan and Secures €11 Million in Interim Financing | WBX Stock News

Wallbox N.V. (WBX) has received a non-compliance notice from the NYSE for failing to meet the required average global market capitalization and stockholders’ equity of at least $50 million. The company must notify the NYSE within 30 business days and has up to 90 days to present a plan to regain compliance, with a potential extension of up to 18 months. Wallbox plans to work with the NYSE to address the issue and restore compliance.

Wallbox receives NYSE non-compliance notice

WALLBOX N V C/WTS 01/10/2026 (TO PUR COM)(WBXWF.US)

Wallbox (WBX) Projected to Post Quarterly Earnings on Wednesday

Wallbox Signs Comprehensive Restructuring Plan and Secures €11 Million in Interim Financing | WBX Stock News

Wallbox receives NYSE non-compliance notice